Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.60 |
| ▸ | BACE1 | P56817 | 12/20 | 0.55 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.54 |
| ▸ | MDM4 | O15151 | 1/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.52 |
| ▸ | CTSD | P07339 | 2/20 | 0.51 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30788717 | 0.94 | F2 (0.58) | F2BACE1NTSR2NTSR1MDM4 | |
| SCHEMBL29373116 | 0.93 | BACE1 (0.61) | F2BACE1NTSR2NTSR1MDM4 | |
| SCHEMBL30517172 | 0.93 | BACE1 (0.60) | F2BACE1NTSR2NTSR1MDM4 | |
| SCHEMBL29611893 | 0.93 | NTSR1 (0.61) | F2BACE1NTSR2NTSR1BACE2 | |
| SCHEMBL30239118 | 0.91 | BACE1 (0.55) | F2BACE1NTSR2NTSR1CTSD | |
| SCHEMBL30054245 | 0.90 | F2 (0.58) | F2BACE1NTSR2NTSR1MDM4 | |
| SCHEMBL30054333 | 0.90 | F2 (0.57) | F2BACE1NTSR2NTSR1MDM4 | |
| SCHEMBL30423322 | 0.90 | ACE (0.56) | F2BACE1NTSR2NTSR1CTSD | |
| SCHEMBL29379622 | 0.90 | BACE1 (0.62) | BACE1CTSDBACE2 | |
| SCHEMBL29603718 | 0.90 | BACE1 (0.62) | BACE1CTSDBACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | TYR, TELO2, MTX2 | F2 967/4885BACE1 3288/4885NTSR2 2257/4885 |
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, TELO2, MTX2 | F2 967/4885BACE1 3288/4885NTSR2 2257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.